CERT1 and cholangiocarcinoma: The survival analysis of the prediction outcome in the TCGA data set in cancer patients with high and low expression of COL4A3BP gene (Figure 5A) also reveals that its high expression was associated with a poor outcome in renal cancer (Figure 5A) and cholangiocarcinoma (CHOL, Figure 5B).